Asthmatics at risk from 'right-handed' drug

Lesser, Frank; Brown, William
November 1991
New Scientist;11/9/91, Vol. 132 Issue 1794, p16
Details the findings of a British researcher that some common asthma inhalers contain a form of drug that may be contributing to the increase in asthma deaths worldwide. Claim that beta 2 agonist drugs include variants that may increase the likelihood of someone with severe asthma suffering fatal attack; Mechanism of action of beta-2 agonists such as salbutamol, marketed as Ventolin; Animal experiments on salbutamol explaining why beta-2 agonists make things worse.


Related Articles

  • The Ideal Inhaler for Asthma Therapy. Buck, Helen // Medical Device Technology;Sep2001, Vol. 12 Issue 7, p24 

    Focuses on the development of ideal inhaler for asthma therapy. Guidelines for ideal inhaler; Basis for asthma therapy; Reasons for the rapid expansion of asthma therapy development.

  • Salmeterol/Fluticasone Propionate Combination: A Viewpoint by Peter J. Barnes. Barnes, P.J. // Drugs;Jun1999, Vol. 57 Issue 6, p941 

    Presents information on the launch of the salmeterol/fluticasone propionate combination inhaler for asthma care. Advantage of a fixed combination inhaler; Potential disadvantage; Results of clinical trials.

  • Inhaler technique. Fernandes, Tanya // Nursing Standard;11/2/2011, Vol. 26 Issue 9, p58 

    A quiz on inhalers for asthma is presented.

  • This Asthma Inhaler Combines A Steroid And A Bronchodilator.  // RN;Dec2000, Vol. 63 Issue 12, p106 

    Features the asthma inhaler drug called Advair Diskus which contains fluticasone propionate and salmeterol inhalation powder. Common adverse effects of the combination inhaler; Recommended drug administration.

  • Inhaled Steroid Use and Asthma Control in Patients with Mild Persistent Asthma. DARBY -STEWART, ANDREA; DACHS, ROBERT; GRABER, MARK A. // American Family Physician;2015 Special Issue, Vol. 91, p1 

    A review of the article "Randomized comparison of strategies for reducing treatment in mild persistent asthma" by S. P. Peters, N. Anthonisen, M. Castro and colleagues, published in the May 17, 2007 issue of the "New England Journal of Medicine," is presented.

  • Proper use of inhalers.  // Mayo Clinic Health Letter;Aug2003, Vol. 21 Issue 8, p7 

    Presents guidelines for the proper use of inhalers to manage asthma. Types of inhalers; Steps for using a metered-dose inhaler; Risks associated with the improper use of inhalers.

  • Super-Efficient Inhaler. Harrar, Sari; Riddle, Judith Springer // Prevention;Jun2002, Vol. 54 Issue 6, p164 

    Reports on the development of a technique called electro-hydrodynamic atomization for inhalers which produces tinier, more-uniform particles and sends more of them directly into the lungs.

  • Long-Acting Beta-Agonists in Asthma. Knobil, Katharine // New England Journal of Medicine;7/9/2009, Vol. 361 Issue 2, p208 

    A letter to the editor is presented in response to an editorial on the risks of the single-agent long-acting beta-agonist (LABA) inhalers in achieving asthma control.

  • Long-Acting Beta-Agonists in Asthma. Kramer, Judith M. // New England Journal of Medicine;7/9/2009, Vol. 361 Issue 2, p208 

    A reply to a letter to the editor is presented about the safety of the single-agent long-acting beta-agonist (LABA) inhalers for asthma indication.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics